Unlike traditional vaccines that rely on inactivated pathogens or recombinant proteins, nucleic acid vaccines deliver DNA or RNA molecules encoding antigens to directly synthesize target proteins in host cells and activate precise immune responses.

This path has shown great potential in the COVID-19 pandemic - it took only 11 months from sequence design to approval for mRNA vaccines, setting a new record in the history of drug development. It not only verifies the rapid response advantage of nucleic acid technology, but also promotes a profound reconstruction of the global biomedical industry.

However, despite the advantages of high efficiency, rapidity, and safety, this technology still faces challenges such as delivery efficiency, reliance on low-temperature storage, and long-term safety to be verified. This article aims to sort out nucleic acid vaccine technology, including concepts, principles, challenges, and future trends, in order to increase readers' understanding and promote industrial development.

 

Industry Overview               

Nucleic acid vaccines, also known as gene vaccines, are to directly introduce exogenous genes encoding a certain antigen protein into animal cells, synthesize antigen proteins with the help of the host cell expression system, and then induce the host to produce an immune response to the antigen protein to achieve the purpose of preventing and treating diseases.

According to the main components, nucleic acid vaccines are divided into DNA vaccines and mRNA vaccines. Nucleic acid vaccines have changed the traditional vaccine model of relying on pathogen treatment. Starting from the genetic level, they have opened up a new path to use human cells to produce immune stimulants, bringing new ideas and methods to disease prevention and treatment.

 

Compared with traditional vaccines, nucleic acid vaccines have many advantages:

• First, the protective efficacy is enhanced. Nucleic acid vaccines can stimulate cellular immunity and humoral immunity at the same time. Compared with traditional vaccines that often trigger a single immune response, such as inactivated vaccines that mainly activate humoral immunity, the dual activation mechanism of nucleic acid vaccines provides stronger immune protection.

 

• Second, the preparation is simple, saving time and effort. Nucleic acid vaccines can be amplified in large quantities, the purification process is relatively simple, and they can be combined with a variety of recombinant plasmids encoding different antigen genes to prepare multivalent vaccines, reducing the consumption of manpower, material resources, and financial resources.

 

• Third, cross-protection between the same species and different strains. Nucleic acid vaccine expression vectors can flexibly transform the target genes they carry and select antigenic determinants in a targeted manner, thereby achieving cross-protection against pathogens of the same species and different strains.

 

• Fourth, it is safer to use. Protein antigens are expressed in host cells, and there is no risk of causing disease due to virulence reversion or residual virulence, nor will it cause serious adverse reactions in the body. The fifth is a lasting immune response. Nucleic acid vaccines have strong immune persistence and can obtain long-term immunity after one vaccination. The sixth is the expansion of treatment areas. Traditional vaccines are mainly used in the field of infectious disease prevention. Nucleic acid vaccines have successfully expanded their application scope to new fields such as tumor treatment, breaking the application limitations of traditional vaccines.

 

Nucleic acid vaccine technology research and development process

The research and development process of nucleic acid vaccines includes six core steps:

• The first is antigen design and sequence screening. Based on the pathogen gene data, the target antigen (such as the new coronavirus S protein) is determined, the coding sequence is optimized through bioinformatics, the 5' cap structure, UTR region and codon preference of mRNA are adjusted, or a DNA plasmid containing a strong promoter is designed.

 

• The second is nucleic acid synthesis. DNA vaccines are amplified and purified by Escherichia coli fermentation plasmids, while mRNA vaccines use in vitro transcription technology to synthesize modified RNA (such as pseudouridine substitution) and remove impurities such as double-stranded RNA.

 

• The third is the construction of a delivery system. DNA vaccines rely on electroporation or chemical carriers to penetrate the cell membrane and nuclear membrane, and mRNA vaccines are encapsulated by lipid nanoparticles (LNPs), and nanoparticles are homogenized by microfluidics technology.

 

• Fourth, in vitro validation. Transfect candidate vaccines into cell lines to detect antigen expression efficiency and innate immune activation (ELISA to measure cytokines)

 

• Fifth, animal model evaluation, testing immunogenicity (neutralizing antibodies, T cell responses) and safety (local/systemic toxicity) in mice or non-human primates. Sixth, production process development. Establish modular production lines (such as continuous flow LNP synthesis), optimize purification processes (HPLC to remove impurities), and formulate quality control standards (nucleic acid integrity, sterility, LNP particle size detection) to lay the foundation for large-scale production.

 

Technical Challenges

Insufficient efficiency and targeting of delivery systems

• Limited delivery efficiency For DNA vaccines, they must not only pass through the cell membrane, but also cross the nuclear membrane to enter the cell nucleus to function. Although electroporation technology can improve its efficiency of entering cells to a certain extent, this technology will cause damage to local tissues, making it necessary to use it with caution in clinical applications.

 

• Although mRNA vaccines do not need to enter the cell nucleus, the current mainstream lipid nanoparticle (LNP) delivery system has a low cell uptake rate and an unsatisfactory intracellular release efficiency, which cannot fully stimulate the immune response.

 

•  Poor organ targeting The current LNP delivery system has obvious organ targeting defects. It is more likely to be enriched in the liver in the body, making it difficult to achieve precise targeted delivery to other organs, such as the lungs expected by respiratory virus vaccines, and organs such as the spleen and lymph nodes that play a key role in the immune response.

 

• For example, when developing mucosal immune vaccines against respiratory viruses, the vaccine needs to be accurately delivered to the lungs to stimulate an effective immune response, but it is difficult to achieve this goal with existing technologies.

 

Stability and storage and transportation bottlenecks

• The low-temperature dependence dilemma of mRNA vaccines mRNA molecules are unstable and will be rapidly degraded as long as RNA enzymes are present in the environment, which makes mRNA vaccines extremely demanding on storage conditions and usually need to be stored in ultra-low temperature environments of -20°C to -70°C.

 

• Although freeze-drying technology, such as the technology used in CureVac's second-generation vaccine, can improve this situation to a certain extent and increase the storage temperature to 2-8°C, the protective agent used in this technology is complex and expensive, which increases the production cost of the vaccine.

 

• Contradiction between DNA vaccine stability and expression efficiency Compared with mRNA vaccines, plasmid DNA has better stability at room temperature and can be stored for a long time.

 

• However, the expression efficiency in vivo is much lower than that of mRNA vaccines. In order to improve the delivery and expression efficiency of DNA vaccines, physical methods such as electroporation or gene guns are often required, but these methods are complicated to operate, have high requirements for equipment and operators, and face many difficulties in large-scale application, making it difficult to meet the needs of large-scale production and vaccination.

 

Long-term safety controversy mRNA vaccines have exposed some potential risks in actual applications, such as the induction of myocarditis and pericarditis.

 

 

Although the incidence is low, about 0.003%, the specific mechanism of occurrence is still unclear. It is speculated that it may be related to the activation of innate immune responses by nucleic acid molecules or the induction of cross-immunity. As for DNA vaccines, although there is no clinical evidence to show that there is a risk of genomic integration, theoretically, this risk does exist.

• Challenges of large-scale production and cost control 1. Process bottleneck of LNP production The key component of LNP, ionizable lipids, such as ALC-0315, has an extremely complex synthesis process and requires ultra-low temperature reaction conditions during the synthesis process.

 

• This not only places extremely high requirements on the reaction equipment, but also has huge equipment investment costs, with a single production line costing more than $100 million. In addition, the PEG lipids in LNP may cause allergic reactions in actual applications.

 

• Although alternative materials, such as PEGylated phospholipids, are being actively developed, the feasibility and effectiveness of these alternative materials in actual production processes still need to be further verified. 2. mRNA purification technology threshold In the process of in vitro transcription to generate mRNA, impurities such as double-stranded RNA will be produced, which will affect the safety and effectiveness of the vaccine.

 

• At present, high-performance liquid chromatography (HPLC) technology is mainly used to purify mRNA, but this technology has obvious limitations. On the one hand, the purification efficiency of HPLC equipment is directly related to the quality of mRNA.

 

• On the other hand, the production capacity of global HPLC equipment is limited. When producing nucleic acid vaccines on a large scale, it cannot meet the demand for rapid and large-scale purification of mRNA, which has become the main bottleneck restricting the expansion of nucleic acid vaccine production capacity.

In recent years, by virtue of its significant advantages, electrosurgical vessel sealer and divider instruments have played a key role in surgery and have been deeply integrated into a rang of specialized surgical procedures. The following outlines its specific applications and advantages in different surgical disciplines:

 

General Surgery: Rapid Sealing, Reduced Trauma
In cholecystectomy, where complex blood vessel network around gallbladder, the instruments can ensure rapid sealing and dividing of vessels, reducing bleeding, minimizing risks and improving visibility.

In herniorrhaphy, where the operative space is limited, the instruments’ precise control allows for safe tissue dissection in narrow spaces, minimizing damage to surrounding nerves and vessels and and supporting postoperative recovery.

 

Gynecologic Surgery: Precision operation for Reproductive Function Preservation

In hysterectomy, where the vessels surrounding uterus are intricate and densely distributed, electrosurgical vessel sealer and divider ensures accurate vessel sealing and dividing while minimizing thermal injury to surrounding organs.
In myomectomy, its adjustable energy output allows for precise fibroid removal while preserving as much healthy uterine tissue as possible, helping preserve future fertility.

 

Cardiothoracic Surgery: A Reliable Choice for High-Risk Areas
Cardiothoracic surgery demands high precision. With its accurate performance, the instruments can safely handle medium and small vessels in the hilum, ensuring sufficient sealing force to withstand intra-thoracic pressure changes.
In cardiac surgery, its pulsed energy release feature minimizes thermal conduction effect to myocardial tissue, enhancing surgical safety.

 

Urologic Surgery: Supporting Recovery, Reducing Risks
In prostatectomy, instruments’ precise seal performance helps preserve sexual nerve function and decrease risk of postoperative complications.
In nephrectomy, its rapid vessel handling properties shorten operative time and reduces renal thermal ischemic injury while combining with minimally invasive techniques.

 

With technology iteration, new generation instruments integrates intelligent feedback system which can monitor tissue status in real-time and adjust energy output automatically, further enhancing seal reliability. Clinical applications shows this technology effectively shortens surgery time, reduces complication rates, and accelerates patient recovery. In the future, through deep integration with digital technologies, the instruments will play a key role in more complex surgical scenarios.

In recent years, electrosurgical vessel sealers/dividers have gained widespread recognition in the field of surgery due to their unique benefits. But what makes them so compelling? Let’s explore the five key clinical advantages that set them apart.

 

1. Minimally Invasive and Tissue-Sparing

One of the most notable advantages of electrosurgical vessel sealers/dividers is their ability to facilitate minimally invasive procedures through small incisions. This not only reduces patient pain and minimizes scarring but also significantly shortens recovery time. Moreover, smaller incisions lower the risk of infections and other postoperative complications, enhancing overall surgical outcomes.

 

2.Easy to Use

The electrosurgical vessel sealer/divider is designed with user-friendliness in mind, ensuring that even less experienced surgeons can operate it with ease. With minimal training requirements, it seamlessly integrates into various surgical workflows without disruption. 

 

3. High Efficiency & Time-Saving

Compared to conventional surgical techniques, the electrosurgical vessel sealer/divider significantly reduces procedure time. By simultaneously sealing and dividing vessels, it enables surgeons to perform operations more efficiently, alleviating stress for both patients and surgical teams, minimizing the risk of complications, and shortening hospital stays.

 

4.Precise Treatment

Electrosurgical Vessel Sealer/ Divider demonstrate exceptional maneuverability, accuracy, and precision during surgery. They are capable of sealing blood vessels with minimal damage to surrounding tissues, effectively reducing the risk of bleeding, bruising, and other complications.

 

5.Cost-Effective

    Although the initial investment in Electrosurgical Vessel Sealer/ Divider instruments may be higher compared to traditional surgical techniques, they are more cost-effective in the long run. The reduction in surgery time and shorter hospital stays significantly lowers overall costs for both patients and healthcare institutions. 

To make veins show quickly for an injection, consider the following safe and effective methods, along with important precautions:



1.  Hydration

• Action: Drink 1-2 glasses of water 30-60 minutes beforehand.  Hydration increases blood volume, making veins more prominent.
  
• Note: Avoid excessive water intake, which can dilute electrolytes.
  
  2.  Apply Warmth
  
• Action: Place a warm compress or heating pad (not too hot) on the area for 5-10 minutes.  Heat dilates veins by increasing blood flow.
  
• Caution: Ensure the temperature is comfortable to prevent burns.
  
  3.  Use Gravity
  
• Action: Let the arm hang down below heart level for 1-2 minutes.  Gravity pools blood in the veins, enhancing visibility.
  
  4.  Exercise the Limb
  
• Action:Open and close your fist repeatedly or squeeze a stress ball for 30-60 seconds.  This engages muscles, pushing blood into superficial veins.
  
  5.  Gentle Tourniquet
  
• Action: Use a soft strap or blood pressure cuff (inflated to low pressure) around the upper arm.  This temporarily restricts venous return, causing veins to bulge.
  
• Caution: Do not leave on longer than 2-3 minutes to avoid nerve damage or ischemia.
  
  6.  Stay Calm
  
• Action: Practice deep breathing to reduce anxiety.  Stress causes vasoconstriction, hiding veins.
  
  7.  Visual Aids
  
• Action:Shine a flashlight under the arm in a dark room;  veins may cast shadows.  Alternatively, gently tap the skin to irritate the vein (avoid aggressive tapping).
  
  8.  Avoid Stimulants
  
• Action:Refrain from caffeine, nicotine, or cold environments for 1-2 hours before, as these constrict blood vessels.
  
  Additional Tips:
  
• Vein Selection: Forearm veins (e.g., cephalic or basilic) are often easier to access than hand veins.
  

  - Professional Help:If veins remain elusive, seek a trained practitioner to avoid complications like bruising or phlebitis.

  
  

  Also welcome to contact us, we are ZD Medical Inc.
  Tel : +86-187 9586 9515
  Email : sales@zd-med.com
  Whatsapp/Mobile : +86-187 9586 9515

Optical coherence tomography (OCT) is a valuable imaging technology with diverse applications in medicine, particularly in ophthalmology and cardiology. Its utility depends on the clinical context, but here’s a comprehensive evaluation of its benefits and considerations:



Key Benefits of OCT

1. Non-Invasive and Safe
   

• OCT uses light waves (e.g., near-infrared) instead of radiation or invasive probes, making it safer for repeated use.
  
• In coronary imaging (cardiology), newer FD-OCT systems eliminate the need for balloon occlusion during procedures, enhancing patient safety.
  
  

2. High Resolution and Precision
   

• OCT provides detailed cross-sectional views of tissues, such as retinal layers or coronary artery structures, enabling early detection of pathologies like macular degeneration, glaucoma, or atherosclerotic plaques.
  
• It can visualize structures behind calcified tissues in coronary imaging, which traditional ultrasound struggles with.
  
  

3. Rapid and Efficient
   

• Retinal OCT scans take 10–15 minutes, requiring minimal patient preparation and no physical contact with the eye.
  
• High-speed coronary OCT systems (e.g., 100 frames/second) reduce procedure time and contrast dye use.
  
  

4. Versatility Across Conditions
   

• In ophthalmology, OCT aids in diagnosing diabetic retinopathy, macular holes, retinal detachment, and glaucoma.
  
• In cardiology, it helps assess coronary artery disease and stent placement.
  
  

5. Support for Research and Innovation
   

• Open-source tools (e.g., OCTproZ on GitHub) enable advanced image processing, fostering innovation in automated disease detection and 3D modeling.
  
  
  
  Considerations and Limitations
  

1. Dependency on Patient Cooperation
   

• Patients must remain still during eye scans, which may be challenging for some individuals.
  
  

2. Cost and Accessibility
   

• While not explicitly mentioned in the search results, OCT machines and specialized training can be expensive, potentially limiting access in resource-constrained settings.
  
  

3. Need for Complementary Tests
   

• Retinal OCT may require additional tests (e.g., visual field analysis) for comprehensive diagnosis.
  
  

4. Technical Limitations
   

• Pupil dilation is sometimes necessary for optimal retinal imaging.
  
• Image quality may vary with patient-specific factors like pupil size.
  
  
  
  —
  
  Conclusion: Is OCT Worth It?
  
  Yes OCT is a worthwhile investment in clinical and research settings due to its non-invasiveness, precision, and versatility. It enhances diagnostic accuracy for conditions like glaucoma, macular degeneration, and coronary artery disease, enabling timely interventions. While cost and technical requirements are considerations, its benefits in improving patient outcomes and supporting cutting-edge research (e.g., AI-driven image analysis via GitHub tools) make OCT a valuable tool in modern medicine.
  
  

  For specific use cases, consult specialists to weigh its advantages against institutional resources and patient needs.

  
  

  Also welcome to contact us, we are ZD Medical Inc.
  Tel : +86-187 9586 9515
  Email : sales@zd-med.com
  Whatsapp/Mobile : +86-187 9586 9515

For parents of infants and toddlers, mealtime can often feel like a full-contact sport. Whether it's puree, snacks, or juice, keeping your little one clean is a challenge. That’s where Baby Bibs come in—simple, effective, and surprisingly versatile, they’re a must-have item in any parent's daily routine.

One of the most convenient innovations in recent years is the Disposable Baby Bib. Unlike traditional cloth options, disposable bibs offer hassle-free cleanup—no need to carry around soiled bibs or worry about stains setting in. Just use it once and toss it away. These bibs are perfect for travel, dining out, or even just those hectic mornings when laundry is the last thing on your mind.

Baby Bibs Disposable products also reduce the risk of lingering bacteria that can result from improper washing or reuse. With secure fit designs, absorbent materials, and waterproof backing, they protect both your child’s clothes and your sanity. Many designs even include crumb catchers and soft neck closures, making them comfortable for your baby and functional for you.

But not all bibs are created equal. That’s why parents are turning to Telijie for premium Baby Bibs that combine quality, safety, and comfort. Telijie's Disposable Baby Bibs are designed with parents in mind—lightweight, leak-proof, and eco-conscious options that fit into your busy lifestyle with ease.

Beyond offering superior Baby Bibs Disposable solutions, Telijie stands out for its exceptional customer service, fast shipping, and flexible bulk ordering options. Whether you're a parent shopping for home use or a retailer sourcing high-quality baby care products, Telijie delivers reliability at every step.

Choose Telijie and experience the difference of a brand that understands what parents need—durability, convenience, and care in every single Baby Bib.

The evolution of modern healthcare technologies increasingly relies on precise, stable, and energy-efficient electronic components. Among these, crystal oscillators play a pivotal role in ensuring the accuracy and reliability of medical devices. As the demand for portable, wearable, and long-term monitoring systems grows, especially for managing chronic diseases, the importance of high-precision crystal components continues to expand.

 

Medical devices require accurate timing to function correctly. Whether it's for measuring heart rhythms through ECG, maintaining time stamps in patient monitoring logs, or synchronizing data in telemedicine platforms, crystals provide the essential clock signals that drive these systems. A crystal oscillator generates a consistent frequency signal, acting as the heartbeat of the device’s internal timing mechanism.

 

In devices such as ECG monitors, crystal oscillators help capture electrical signals from the heart at precise intervals. The timing must remain stable over extended periods, regardless of temperature fluctuations or power variations. This is where low-frequency crystals, especially those operating at 32.768kHz, offer significant advantages due to their inherent power efficiency and long-term accuracy.

 

A representative solution is the JGHC H31 series, which has been recently introduced in a compact 3.2x1.5mm package. Designed to meet the stringent requirements of the medical electronics sector, this series offers a frequency stability of ±20ppm across a broad operating temperature range of -40°C to +85°C. Such specifications ensure stable performance in both handheld and wearable medical devices that may be exposed to varying environmental conditions.

 

The H31 series 32.768kHz crystal oscillator is particularly well-suited for applications that require low power consumption and continuous uptime. In long-term ECG acquisition systems, for instance, the oscillator functions as a highly stable reference clock, allowing the device to operate reliably over extended durations without the need for frequent recalibration or power cycling.

 

Additionally, remote patient monitoring equipment, often used in home-care settings, demands components that are both compact and robust. The small footprint of the H31 series enables integration into space-constrained designs, while its wide temperature tolerance and high stability reduce the risk of performance degradation over time.

 

As the global population ages and chronic illnesses become more prevalent, the medical industry is experiencing a shift toward preventive and remote care. Analysts predict that the global medical electronic crystal oscillator market will exceed US$5 billion by 2030. A significant portion of this growth is attributed to the rising demand for devices supporting chronic disease management, including blood pressure monitors, wearable cardiac monitors, and portable diagnostic kits.

 

In this context, high-precision timing components like those in the H31 series become indispensable. Their ability to maintain timing accuracy under challenging conditions contributes directly to device reliability and patient safety. Furthermore, the move toward more connected and data-driven healthcare systems places greater emphasis on synchronization and timestamp accuracy, which are only achievable with precision oscillators.

 

Design engineers and product developers in the medical technology space must therefore prioritize timing components that combine thermal stability, miniaturization, and energy efficiency. As seen with the JGHC 32.768kHz H31 series, such products can address these multifaceted requirements, enabling reliable operation in both professional healthcare settings and personal health monitoring devices.

 

In conclusion, quartz crystals are more than just timing elements—they are foundational to the performance and trustworthiness of medical electronics. As healthcare continues to evolve toward more intelligent and mobile solutions, the demand for high-accuracy, low-power crystal oscillators will only become more central to innovation and patient care.

 

The Sex-Hormo Detection Kit is a comprehensive tool designed to assess key hormones involved in reproductive health. This kit measures levels of hormones such as testosterone, estradiol, progesterone, and others that play crucial roles in sexual function, fertility, and overall endocrine health. Hormone levels is essential for diagnosing various conditions, including infertility, hormonal imbalances, and disorders related to sexual development.

Clinically, Hormone testing is vital for a range of applications. It aids in fertility assessments for both men and women, helps monitor hormone replacement therapy, and assists in diagnosing conditions such as polycystic ovary syndrome (PCOS) and hypogonadism. By providing accurate hormone profiles, clinicians can make informed treatment decisions, ultimately improving patient outcomes and quality of life.

Poclight's Human Sex-Hormon-Test (CLIA)-Kits employs a homogeneous chemiluminescent immunoassay method, which simplifies the testing process significantly. With a straightforward detection protocol, Poclight assay allows for direct testing, making it much more convenient than traditional methods. Results are available in as fast as 5 minutes. The flexibility of the kit allows for a rich combination of tests, accommodating various clinical requirements and ensuring a wide linear range for accurate measurements.

Cost-effectiveness is a key feature of Poclight's detection kit. Individual packaging lyophilized reagent kits that can be stored at room temperature for 18-36 months, eliminating the need for refrigeration. This unique production process not only reduces storage and transportation risks but also keeps testing costs low.

Poclight's Human Sex Hormon 8-Items Detection Kit stands out as a powerful tool for assessing reproductive health. With its user-friendly operation, rapid results, and high cost-effectiveness, it is tailored to meet the needs of modern healthcare providers. 

In laboratory environments and precision industries, maintaining cleanliness is crucial. Any dust, fiber residue, or moisture can interfere with delicate instruments, affecting accuracy and performance. This is where Laboratory dust-free wiping paper becomes essential. Designed for high-precision cleaning, it ensures that sensitive surfaces remain uncontaminated, making it a reliable choice for laboratories, electronics manufacturing, and medical applications.

Superior Material & Performance

Our Precision instrument wiping paper is crafted from a high-quality blend of pure wood pulp and scrim reinforcement. This unique composition gives it exceptional strength, ensuring it won’t tear easily, even when wet. Unlike traditional wipes, which may leave behind fibers or break apart upon contact with moisture, our scrim paper maintains integrity, providing a seamless cleaning experience. Additionally, it is environmentally friendly and fully biodegradable, making it a responsible choice for industries aiming to reduce waste.

Outstanding Absorbency & Durability

When dealing with precision instruments, every detail matters. Our wiping paper offers excellent absorbency, effectively removing liquids, oils, and fine dust particles. Its reinforced structure provides extra durability, allowing it to withstand rigorous wiping without disintegration. Whether used for cleaning glassware, wiping laboratory benches, or maintaining high-tech equipment, this product delivers superior performance.

Versatility Across Industries

Beyond laboratories, our scrim paper is widely utilized in medical settings, optical lens manufacturing, aerospace engineering, and semiconductor production. Its dust-free and lint-free properties make it ideal for applications requiring meticulous cleanliness. The ability to absorb both oil and water-based contaminants further enhances its versatility, ensuring it meets the stringent standards of various industries.

Why Choose Telijie’s Laboratory Dust-Free Wiping Paper?

At Telijie, we are committed to providing high-quality wiping solutions tailored to professional needs. Our Laboratory dust-free wiping paper is manufactured with strict quality control measures, ensuring consistency and reliability in every batch. Moreover, we offer customization options, including size and packaging, to meet specific industry requirements. With our strong production capacity, efficient delivery service, and customer-first approach, we ensure that our partners receive the best products with unparalleled support.

For those seeking a high-performance, eco-friendly, and durable wiping solution, Telijie’s Laboratory dust-free wiping paper stands out as the perfect choice. Contact us today to learn more about how our advanced wiping solutions can benefit your industry!

ZD Medical is a professional manufacturer of IPL, with the advanced technology and diligent engineers, our IPL is suitable to most demands from Market.

Here are our 7 advantages:

1.Anti-pinch design; No angle limitation

2.Microelectronics technology; Highly integrated circuit; More reliable and safe

3.Vertical trolley; Easy to move; Small footprint

4.Ergonomically designed treatment head; All-in-one handle; Embedded handheld slot; Pluggable filter technology; Meet individual needs

5.Large touch screen display; Flull menu display; Man-machine interactive interface; Simple and clear operation

6.Arc pendulum provides larger operating space for treatment

7.Hidden treatment head interface; Smoother and more compact